1. and : 5(, OR 4)-(3: 3-Bis(2-chloroethyl)-1-triazeno) imidazole-4(or 5)-carboxamide (NSC 82196). Clinical brochure. Cancer Chemother. Rep. Part 3, 1968; p. 63.
2. , , and : Adaption of a colorimetric determination of 5-(3, 3-Dimethyl-1-triazeno) imidazole-4-carboxamide (NSC 45388) and 5-(3, 3-Bis (2-chloroethyl)-1-triazeno) imidazole-4-carboxamide (NSC 82196) to blood. Cancer Chemother. Rep. Part 1; 1969, p. 199.
3. , , , , and : Influence of treatment schedules and route of administration on the chemotherapy of murine leukemia L 1210 with 4 (or 5)-3, 3-Bis (2-chloroethyl)-1-triazeno) imidazole-4 (or 5)-carboxamide (NSC 82196). Cancer Chemother. Rep. Part 1, 1968; p. 715.
4. Studies on Antitumor Agents. I. Antitumor Activity of 5 (4)-Amino-4 (5)-imidazolecarboxamide Analogs